SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (20171)5/7/1998 9:10:00 AM
From: Mudcat  Read Replies (1) | Respond to of 32384
 
henry - I know the article focused on anti-angiogenisi companies but it also stated:
<And there are a host of tiny biotech companies testing agents in humans that use other techniques that have wiped out tumors in lab rodents. These companies include Antigenics, a closely held New York company, as well as Targeted Genetics, Vical Pharmaceuticals and Imclone Systems.>

I assumed this paragraph would have mentioned Lgnd.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News